Abstract:Objective To assess the safety and efficacy of direct intra-coronary injection of tirofiban followed by transfusion via vein in patients with acute myocardial infarction(AMI) undergoing emergency percutaneous coronary intervention(PCI).Methods Between Dec 2008 and Dec 2010,74 patients with AMI were randomly assigned into tirofiban group and conventional PCI group,37 patients were given tirofiban intra coronary artery undergoing emergency PCI in tirofiban group,followed with continuous transfusion via vein,while the other 37 patients were treated by conventional PCI during the same period,who were only given tirofiban via vein undergoing emergency PCI.The basic clinic condition,TIMI thrombus score,TIMI flow grades,corrected TIMI frame count,TIMI myocardial perfusion and the resolution of the sum of ST-segment elevation(sumSTR) at 90 minutes after the procedure,recent cardiaovascular events,bleeding events before and after the procedure and left ventricular ejection fraction(EF) were compared between the two groups.Results No significant differences were shown in basic clinic condition,TIMI Ⅲ flow grades acquirtion,recent major cardiaovascular events and bleeding events between the two groups(P 0.05),but the former group acquire more TMP Grade 2 or 3 than the latter group(94.6% vs 67.6%,P = 0.003) and lower corrected TIMI frame count(91.9% vs 64.9%,P = 0.005),and patients received tirofiban from direct injection into coronary artery were more likely to achieve higher sumSTR(67.6% vs 27.0%,P = 0) and EF after one week [(56.62 ± 6.897) vs(51.59 ±6.817),P =0.002) ].Conclusion The study demonstrates that direct injection of tirofiban into crornary artery can be safe and efficient,which can improve the myocardial microcirculation reperfusion and patients’short-time prognosis,but long-time prognosis still needs more investigations.

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

Efficacy and safety of fondaparinux Na in treatment of acute coronary syndrome patients with emergency percutaneous coronary intervention supported by IABP

Fondaparinux Sodium for Anticoagulant Therapy After Primary Percutaneous Coronary Intervention: A Single-Center Randomized Trial in China

Effects of tirofiban on non-ST-segment elevation acute myocardial infarction

Comparison of Efficacy and Safety of Native Eptifibatide Vs. Tirofiban in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention

The efficacy and safety of Tirofiban in percutaneous coronary intervention for non-ST elevation acute coronary syndrome patients

Influence of intracoronary tirofiban application on coronary blood flow,endothelial function and in-flammatory factors in AMI patients

Effect of Intracoronary Tirofiban in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Impacts on Peri-procedure Outcome of Patients with Acute Coronary Syndrome Undergone Percutaneous Coronary Intervention when Combined with Intravascular Tirofiban Administration

Effect of Bivalirudin on Primary Percutaneous Coronary Intervention in Patients With Acute ST-elevation Myocardial Infraction

Safety and Efficacy Study of Direct Intra-Coronary Injection of Tirofiban in Patients with Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention

Safety and Long-term Efficacy of Tirofiban in Interventional Treatment of Patients with Acute Coronary Syndrome

Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis.

Application of Thrombus Aspiration Plus Tirofiban in Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

Clinical Study of the Effect of Fondaparinux on Hemorheology in Treating Acute Coronary Syndrome

Clinical efficacy of China-made Tirofiban in patients with acute coronary syndrome undergoing PCI

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials.

[The safety and efficacy of pre-treatment with enoxaparin (Clexane) in acute coronary syndrome patients undergoing percutaneous coronary intervention].

Effect of tirofiban in STEMI patients undergoing emergency percutaneous coronary intervention

Efficacy and Safety of Bivalirudin Application During Primary Percutaneous Coronary Intervention in Older Patients with Acute ST-segment Elevation Myocardial Infarction